<p>BALB/c mice were challenged three weeks after the last vaccination in one ear with a needle injection of 2000 purified <i>L. major</i> metacyclics or exposed in one ear to bites of 10 <i>L. major</i>-infected sand flies (<i>P. duboscqi</i>). (A and C) Ear lesion thickness was measured in mice vaccinated with GLA-SE (•), KSAC+GLA-SE (▪), or L110f+GLA-SE (▴) and challenged with needle (A) or infected-sand fly bites (C). Panels show representative ears of vaccinated mice eight weeks after challenge. (B and D) Parasite load determined by Real-Time PCR eight weeks after challenge with needle (B) or infected-sand fly bites (D). Statistical significance was determined for KSAC+GLA-SE- or L110f+GLA-SE-vaccinated mice compared to the GLA-SE-vacci...
<p>Worm burden (mean +/− SD) in control mice injected with PBS versus mice immunized with r<i>Sm</i>...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
<p>Mice (5/group) received a prime immunization on d0 with rH5 VN (50 ng) either alone, with SE, or ...
<p>Mice were vaccinated subcutaneously with 10 µg KSAC+20 µg GLA-SE, 10 µg L110f+20 µg GLA-SE, or 20...
<p>Mice immunized with PpSP15, PpSP44 or CTL DNA were challenged with 500 <i>L. major</i> metacyclic...
<p>(<b>A</b>) Representative parasite load and percent metacyclics in the gut of infected <i>P. dubo...
<p>Mice immunized in the right ear with CTL DNA (•), PpSP15 (○), PpSP42 (□), PpSP44 (▪), SGH (▴) or ...
Background: Recombinant KSAC and L110f are promising Leishmania vaccine candidates. Both antigens fo...
<p>(<b>A and B</b>) Ears of naïve, age matched control mice (Naïve), or mice with a healed but chron...
<div><h3>Background</h3><p>Recombinant KSAC and L110f are promising <em>Leishmania</em> vaccine cand...
<p>Mice were vaccinated subcutaneously with 10 µg KSAC+20 µg GLA-SE, 10 µg L110f+20 µg GLA-SE, or 20...
BALB/c mice (ten mice per group) were immunized in the right ear three times at two-week intervals w...
<p>Balb/c mice were vaccinated in a prime-boost regimen consisting of two subcutaneous doses, admini...
<p>BALB/c mice were vaccinated by the subcutaneous route three times every three weeks with either 2...
<p>C57BL/6 mice were immunized in the right footpad with <i>L. tarentolae CPA/CPB/EGFP</i> (G1; rLiv...
<p>Worm burden (mean +/− SD) in control mice injected with PBS versus mice immunized with r<i>Sm</i>...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
<p>Mice (5/group) received a prime immunization on d0 with rH5 VN (50 ng) either alone, with SE, or ...
<p>Mice were vaccinated subcutaneously with 10 µg KSAC+20 µg GLA-SE, 10 µg L110f+20 µg GLA-SE, or 20...
<p>Mice immunized with PpSP15, PpSP44 or CTL DNA were challenged with 500 <i>L. major</i> metacyclic...
<p>(<b>A</b>) Representative parasite load and percent metacyclics in the gut of infected <i>P. dubo...
<p>Mice immunized in the right ear with CTL DNA (•), PpSP15 (○), PpSP42 (□), PpSP44 (▪), SGH (▴) or ...
Background: Recombinant KSAC and L110f are promising Leishmania vaccine candidates. Both antigens fo...
<p>(<b>A and B</b>) Ears of naïve, age matched control mice (Naïve), or mice with a healed but chron...
<div><h3>Background</h3><p>Recombinant KSAC and L110f are promising <em>Leishmania</em> vaccine cand...
<p>Mice were vaccinated subcutaneously with 10 µg KSAC+20 µg GLA-SE, 10 µg L110f+20 µg GLA-SE, or 20...
BALB/c mice (ten mice per group) were immunized in the right ear three times at two-week intervals w...
<p>Balb/c mice were vaccinated in a prime-boost regimen consisting of two subcutaneous doses, admini...
<p>BALB/c mice were vaccinated by the subcutaneous route three times every three weeks with either 2...
<p>C57BL/6 mice were immunized in the right footpad with <i>L. tarentolae CPA/CPB/EGFP</i> (G1; rLiv...
<p>Worm burden (mean +/− SD) in control mice injected with PBS versus mice immunized with r<i>Sm</i>...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
<p>Mice (5/group) received a prime immunization on d0 with rH5 VN (50 ng) either alone, with SE, or ...